Evidence map›Paper›PMID 37627859›Full record

ArticleBioengineering (Basel, Switzerland)2023

AI-Based Cancer Detection Model for Contrast-Enhanced Mammography.

Clément Jailin, Sara Mohamed, Razvan Iordache, Pablo Milioni De Carvalho, Salwa Yehia Ahmed, Engy Abdullah Abdel Sattar, Amr Farouk Ibrahim Moustafa, Mohammed Mohammed Gomaa, Rashaa Mohammed Kamal, Laurence Vancamberg

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Clément JailinGE HealthCare, 283 Rue de la Miniére, 78530 Buc, France.ORCID 0000-0002-6414-6039
Sara MohamedGE HealthCare, 283 Rue de la Miniére, 78530 Buc, France.
Razvan IordacheGE HealthCare, 283 Rue de la Miniére, 78530 Buc, France.
Pablo Milioni De CarvalhoGE HealthCare, 283 Rue de la Miniére, 78530 Buc, France.
Salwa Yehia AhmedBaheya Foundation for Early Detection and Treatment of Breast Cancer, El Haram, Giza 78530, Egypt.
Engy Abdullah Abdel SattarBaheya Foundation for Early Detection and Treatment of Breast Cancer, El Haram, Giza 78530, Egypt.
Amr Farouk Ibrahim MoustafaBaheya Foundation for Early Detection and Treatment of Breast Cancer, El Haram, Giza 78530, Egypt.
Mohammed Mohammed GomaaBaheya Foundation for Early Detection and Treatment of Breast Cancer, El Haram, Giza 78530, Egypt.
Rashaa Mohammed KamalBaheya Foundation for Early Detection and Treatment of Breast Cancer, El Haram, Giza 78530, Egypt.
Laurence VancambergGE HealthCare, 283 Rue de la Miniére, 78530 Buc, France.
Cairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe recent development of deep neural network models for the analysis of breast images has been a breakthrough in computer-aided diagnostics (CAD). Contrast-enhanced mammography (CEM) is a recent mammography modality providing anatomical and functional imaging of the breast. Despite the clinical benefits it could bring, only a few research studies have been conducted around deep-learning (DL) based CAD for CEM, especially because the access to large databases is still limited. This study presents the development and evaluation of a CEM-CAD for enhancing lesion detection and breast classification. MATERIALS &

methodsA deep learning enhanced cancer detection model based on a YOLO architecture has been optimized and trained on a large CEM dataset of 1673 patients (7443 images) with biopsy-proven lesions from various hospitals and acquisition systems. The evaluation was conducted using metrics derived from the free receiver operating characteristic (FROC) for the lesion detection and the receiver operating characteristic (ROC) to evaluate the overall breast classification performance. The performances were evaluated for different types of image input and for each patient background parenchymal enhancement (BPE) level.

resultsThe optimized model achieved an area under the curve (AUROC) of 0.964 for breast classification. Using both low-energy and recombined image as inputs for the DL model shows greater performance than using only the recombined image. For the lesion detection, the model was able to detect 90% of all cancers with a false positive (non-cancer) rate of 0.128 per image. This study demonstrates a high impact of BPE on classification and detection performance.

conclusionThe developed CEM CAD outperforms previously published papers and its performance is comparable to radiologist-reported classification and detection capability.

Indexed as

breast cancercancer detectioncomputer aided detectioncontrast-enhanced mammographydeep learning

Identifiers

PMID37627859
PMCPMC10451612
OpenAlexW4385948638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.